library.onepin.app/resveratrol Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Longevity Dietary supplement

Resveratrol

trans-Resveratrol · Trans-Resveratrol

250mg – 500-1000 mg Oral Daily

Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic stilbene compound found in red grape skins, red wine, peanuts, blueberries, and Japanese knotweed (Polygonum cuspidatum, the source of most commercial supplement-grade resveratrol). Discovered as a phytoalexin (plant defense compound) in 1939, resveratrol gained worldwide attention in the 1990s after media coverage of the 'French Paradox' - the observation that French populations have low cardiovascular disease rates despite high saturated fat intake, attributed in part to red wine consumption.

Quick Start
Route
Oral
Start low
250mg Oral
Frequency
Daily
Timing
Anytime

Take with a fatty meal to improve absorption (resveratrol is fat-soluble). Most clinical trials use 150-500mg/day. Pairs naturally with NR/NMN (substrate for SIRT1) and with quercetin (synergistic AMPK activation). Trans-resveratrol form (>98% trans isomer) is preferred over cis.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
250mg · Oral · Daily
conservative starter
250mg
Daily
Standard
Sirtuin Activation & Antioxidant
500-1000 mg · Oral · Daily
human clinical trial · Bhatt et al. 2012 (Nutr Res)
Bioavailability is notoriously poor. Micronized forms or combining with dietary fats enhances absorption.
500-1000 mg
Daily
01

How it works

Resveratrol's most-discussed mechanism is allosteric activation of SIRT1, the NAD+-dependent histone deacetylase that regulates gene expression, mitochondrial biogenesis (via PGC-1alpha deacetylation), and cellular stress responses. SIRT1 activation mimics caloric restriction effects and is associated with extended lifespan in lower organisms. However, direct SIRT1 activation by resveratrol is now debated - some studies show resveratrol's apparent SIRT1 activation is an artifact of fluorogenic substrate assays, with the real mechanism being indirect (via AMPK activation upstream).

The more robust mechanism is AMPK (AMP-activated protein kinase) activation, which orchestrates a metabolic shift toward catabolism (fatty acid oxidation, glucose uptake, mitochondrial biogenesis) and away from anabolism (lipogenesis, protein synthesis). AMPK activation by resveratrol is dose-dependent and reproducible. Downstream effects include PGC-1alpha activation, autophagy induction (mTOR inhibition), and reduced inflammatory cytokine production via NF-kB inhibition.

Additional mechanisms include: direct antioxidant activity (scavenging free radicals via the polyphenol structure), eNOS upregulation (improving endothelial NO production for vascular health), estrogen receptor modulation (resveratrol is a phytoestrogen with mixed agonist/antagonist activity depending on tissue), and modulation of multiple inflammatory pathways (COX-2, iNOS, NF-kB). The pleiotropic activity makes mechanism attribution difficult but explains the broad range of clinical effects observed.

02

What to expect

Early
Days 1–7

Days 1-14: Subclinical AMPK activation. No subjective change for most.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

Indeed, toxicity and adverse effects were reported following consumption of RE; therefore, extensive future studies on the long-term effects, as well as the in vivo adverse effects, of RE supplementation in humans are needed.

Indeed, toxicity and adverse effects were reported following consumption of RE; therefore, extensive future studies on the long-term effects, as well as the in vivo adverse effects, of RE supplementation in humans are needed.

Potential Adverse Effects of Resveratrol: A Literature Review. International journal of molecular sciences · 2020 · PMID 32197410

Evidence scope. Literature review of potential adverse effects; broad safety boundary without exact card-dose attribution.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 250mg via Oral, Daily. No checked live PubMed abstract supported this complete molecule/formulation/route/dose/frequency combination.

Mechanism: Resveratrol's most-discussed mechanism is allosteric activation of SIRT1, the NAD+-dependent histone deacetylase that regulates gene expression, mitochondrial biogenesis (via PGC-1alpha deacetylation), and cellular stres. No checked live abstract supported this full mechanistic claim at the card's formulation/route without extrapolation.

Exact-regimen safety: Generally well tolerated at standard doses (150-500mg/day). The verified safety row does not establish incidence or severity at every element of the card's exact regimen.

04

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

CurcuminBoth polyphenols with anti-inflammatory effects through different pathways. Compatible no expected conflicts.
Omega-3 Fatty AcidsAnti-inflammatory complement; resveratrol is fat-soluble so taking with omega-3 fish oil improves absorption.
Nicotinamide Riboside (NR) / NMNResveratrol activates SIRT1; SIRT1 requires NAD+ as substrate. NR/NMN provides the substrate, resveratrol activates the enzyme. Mechanistic synergy widely used in longevity protocols.
QuercetinBoth are polyphenols with overlapping AMPK activation. Quercetin also inhibits resveratrol's metabolizing enzymes (sulfotransferases), boosting effective bioavailability.

Keep separate

Anticoagulants (warfarin, apixaban, rivaroxaban)Resveratrol has antiplatelet activity and CYP2C9 inhibition that can potentiate anticoagulant effects. Bleeding risk increase. Discuss with prescribing physician before combining.
Estrogen-sensitive cancers (active or recent history)Resveratrol has phytoestrogen activity (mixed agonist/antagonist depending on tissue). Caution in active breast cancer or other estrogen-driven malignancies. Discuss with oncologist.
CYP3A4 substrates (many medications)Resveratrol inhibits CYP3A4 modestly, potentially raising levels of various medications including statins, some immunosuppressants, calcium channel blockers. Review medication list with pharmacist.
Surgery (within 2 weeks)Antiplatelet activity can increase intraoperative bleeding risk. Discontinue 2 weeks before scheduled surgery.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

05

Pharmacokinetics

Illustrative plasma concentration · 47 h
Half-life
~9-14 hours

Parent compound + active metabolites

Peak · Tmax
~30-90 minutes

Oral

Elimination
~24-48 hours
Bioavailability

Very low (~1%) as parent compound due to extensive first-pass sulfation and glucuronidation. Most circulating resveratrol is conjugated metabolites. Bioavailability boosted by piperine, fatty meal, or liposomal formulations.

Duration of action

Effects sustained with daily dosing. Skipping doses results in gradual loss of cellular signaling effects over 1-3 days.

Clearance

Hepatic conjugation (sulfotransferases SULT1A1, glucuronosyltransferases UGT1A1). Biliary and renal excretion of conjugates. Some enterohepatic recirculation.

Storage. Store at room temperature (20-25C) in a cool, dry, dark place. Resveratrol is light-sensitive - keep in opaque containers. Capsules shelf-stable for 18-24 months. Trans-resveratrol can isomerize to less-active cis form with light/heat exposure - quality brands use light-protected packaging.

06

Regulatory status

Classified as a dietary supplement in the US (no FDA pre-approval). Available widely over the counter. EU permits resveratrol as food supplement up to 150mg/day from synthetic sources, higher from food/extract sources. Generally Recognized as Safe at typical supplement doses.

Put it to work

Calculate, log & track

Open Resveratrol straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Resveratrol in the app →

Go deeper

The guide & community

The complete Resveratrol walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.